GABA A receptor agonists act in the suprachiasmatic nucleus (SCN) to reset circadian rhythms during the day, but inhibit the ability of light to reset rhythms during the night. In the present study, we examined whether these paradoxical differences in the effect of GABA A receptor stimulation on the circadian system are mediated by separate GABA A receptor subtypes. 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP), a GABA A receptor agonist, preferentially binds GABA A receptors in extrasynaptic locations. THIP, muscimol (a GABA A agonist), or vehicle were microinjected into the SCN region of Syrian hamsters free-running in constant darkness during the mid subjective day, early subjective night, or late subjective night. The subjective night injections were followed by a light pulse or sham control. Behavioral phase shifts of wheel running rhythms and both Period1 (Per1) and Per2 mRNA levels in the SCN were assessed. Animals that received THIP during the subjective day did not exhibit significant phase alterations. During the early and late subjective night, however, THIP abolished the phase-shifting effects of light and the ability of light to increase Per1 and Per2 mRNA levels. The ability of NMDA to phase-shift wheel running rhythms was also attenuated by THIP. Together these data demonstrate that THIP does not produce phase shifts during the subjective day, but does inhibit the ability of light to produce phase shifts. Thus, extrasynaptic GABA A receptors appear to play a role in regulating light input to the SCN, while a different population of GABA A receptors appears to be responsible for daytime effects of GABA.
Introduction:
In mammals, the synchronization of physiology and behavior with the earth's 24-hour period (i.e., entrainment) is maintained by a master circadian clock, the suprachiasmatic nucleus (SCN). Cells within the SCN generate endogenous rhythms through an inhibitory feedback-loop comprised of the transcription and translation of core circadian clock genes (12, 14, 27 ). The SCN is reset daily to match the earths period by light and other environmental cues (zeitgebers) acting to alter the expression of these clock genes and their products (2, 12, 27, 43) . Environmental time cues are only capable of resetting the circadian system at discrete phases of the circadian cycle. Photic cues reset the timing of the clock during the night phase of the endogenous rhythm, while a number of nonphotic stimuli reset the clock during the day (19, 34) .
The classical inhibitory neurotransmitter γ-aminobutyric acid (GABA) (8, 11, 29, 32) , its receptors (16, 35, 41) , synthesis enzymes (21, 22, 53) , and transporters (4) are in nearly every cell in the SCN. There is substantial evidence both in vivo and in vitro that GABA plays a major role in the regulation of SCN neurons. Electrophysiological evidence indicates that tonic input, mediated by the GABA A receptor, is received by nearly every SCN cell (10, 26) and that the source of this GABA seems to be both within and outside the SCN (24, 50) .
These local GABA connections have been implicated in synchronizing electrical activity in SCN cells and regional cell groups (3, 28, 45, 50, 51) . Other investigations have implicated GABA in the entrainment pathway of the SCN.
Activation of GABA A receptors in the SCN phase shifts the circadian clock during the subjective day (20, 46) , while activation of either GABA A or GABA B receptors inhibits light input during the night (17, 18, 36, 38) .
GABA A receptors in the brain are heterogeneous and exist as pentomeric constructs of at least 18 possible subunits. Functional receptors are formed from specific arrangements of subunits with the particular combination of subunits determining the pharmacological profile and/or cellular location of the receptor (9, 15, 54) . We therefore hypothesized that different subpopulations of GABA A receptors in the SCN are responsible for the multiple actions of GABA. To date, there have been no investigations to examine whether multiple GABA A receptor subunit constructs are responsible for the multiple actions of GABA on circadian processes. In this study we focus on a subtype of GABA A receptors possessing the δ subunit. This subunit is responsible for directing the receptors to extrasynaptic locations where they are believed to respond to tonic levels of GABA in the extracellular space (40) . THIP (4,5,6,7-tetrahydroisoxazolo [5,4- c]pyridin-3-ol) is a GABA A receptor agonist that preferentially activates these extra-synaptic receptors which are found primarily in areas of the hippocampus, cortex, and thalamus, but its potential ability to modulate circadian processes remains ambiguous (5-7, 41, 42, 48) . The present study took advantage of sitedirected injections of THIP in the SCN to investigate the role of these extrasynaptic receptors in GABA's action on the circadian system. Animals were deeply anesthetized with a cocktail of ketamine (120 mg ⁄ kg) and xylazine (25 mg ⁄ kg) before a 26-gauge guide cannula (11 mm total length) aimed at the SCN was stereotaxically implanted. The skull was leveled before implantation using bregma and lambda as reference points. Coordinates were 0.9 mm anterior and 1.7 mm lateral to bregma. With a 32-gauge injection needle inserted into the cannula, the final depth of injection was 7.2 mm below dura. A 10º angle toward the midline was used for implantations. The cannula was affixed to the skull using stainless steel screws and cranioplastic cement. receptor agonists. The rank order potency (EC 50 ) for these agonists has been estimated from two types of δ subunit containing receptor and is, muscimol > GABA > THIP, with the magnitude of the differences dependent on the receptor construct (1, 6, 49) . THIP acts as a superagonist at receptors with the δ subunit and elicits a 50% greater peak response than either GABA or muscimol (1, 6, 49) . Drugs were administered at circadian time (CT) 6, 13.5 or 20 (CT 12 is defined by convention as activity onset). A phase response curve was constructed for THIP by treatments at additional timepoints (CT 0, 2, 10 and 16).
Materials and Methods

Animals
Microinjections of drugs dissolved in 0.9% saline were given using a 16-mm, 32-gauge needle attached by polyethylene tubing to a 1 µl Hamilton syringe.
Injections were given to hamsters gently restrained by hand in dim red illumination (< 5 lux). The needle was left in place for at least 20 seconds after injection. Microinjections during the night were followed by a light pulse (15 Animals in the phase response curve cohort received two treatments of THIP at randomly assigned phases. At the end of each study brains were sectioned (50μm), mounted on slides, stained with cresyl violet and examined using a light microscope in order to verify the site of injection.
Cohorts of animals treated with THIP (22 nmol) at CT 13.5 and 20 were assigned for in situ hybridization processing. These animals were killed by rapid decapitation 3h following injections at CT 6 or 1.5h following injections at CT 13.5 and 20. Brains were quickly removed under dim red light and frozen on dry ice.
Coronal cryostat sections (20μm) collected in four sets on Superfrost Plus slides (Fisher) were used for in situ hybridization. Whole and sectioned brains were stored at -80° C.
In situ hybridization: These methods have been described previously (13, 39) . Phase shifts: Phase shifts were calculated using the linear regression method. Regression lines were calculated from activity onsets for both the seven days preceding treatment and days 3-7 following treatment (day zero = day of treatment). These regressions were used to predict the onset on day zero, and the difference between these two predicted onsets was the phase shift. To determine statistical significance (ascribed at p < 0.05), student's t-test for paired samples or ANOVA was used. Post hoc pair-wise comparisons were made using the Tukey multiple comparisons test.
Results
Early subjective night: THIP prevented the phase-altering effects of light when microinjected into the SCN region during the subjective night. A light pulse delivered in early night (CT 13.5; i.e. 1.5 hours after activity onset) to animals pretreated with saline, resulted in significant phase delays of 74 ± 10 min (mean ± SEM; n = 7; Figure 1 In a separate study we found this inhibitory action of THIP to be dose dependent ( Figure 3 ). Cohorts of hamsters received five different concentrations of THIP (n = 9, saline; n = 7, 1.2 nmoles; n = 9, 2.4 nmoles; n = 9, 6.0 nmoles; n = 6, 12.0 nmoles; n = 9, 24.0 nmoles) prior to a light pulse at CT 13. Phase shifts induced by THIP alone were investigated across the circadian day in order to generate a phase-response curve (n = 3-8 / time point).
THIP had little effect on its own, and induced only small alterations in phase across the circadian day. We did not determine the significance of these shifts due to the lack of vehicle control injections for comparison. (CT 0, n=3, 30 ± 15 ;
CT 2, n = 3, 4 ± 8; CT 6, n = 7, 1 ± 6; CT 10, n = 8, -22 ± 9; CT 13, n = 7, -19 ± 8; CT 16, n = 6, -39 ± 7; CT 20, n = 4, -21 ± 10).
Discussion
THIP abolished the ability of light to phase-shift behavioral rhythms and alter Per gene expression in the SCN during the early and late subjective night.
Microinjection of THIP in the SCN region immediately prior to a light pulse prevented both behavioral phase delays during the early night, and behavioral phase advances during the late night. In the SCN, THIP blocked the light-induced increases in Per1 and Per2 mRNA in the early night, and Per1 in the late night.
During the midday, however, THIP microinjection had no phase-altering effect.
These data suggest that THIP sensitive GABA A receptors are responsible for the inhibitory effects of GABA on light, but not the direct actions of GABA agonists during the day. and Per2 mRNA increases indicating that it acts upstream of changes in Period mRNA. Therefore, our evidence suggests that THIP attenuated phase shifts during the subjective night by acting directly on cells in the SCN to prevent Per1 and Per2 expression and phase shifts. This photic inhibitory effect of THIP, however, was incomplete. Thus, we cannot eliminate the possibility that THIP is also acting through presynaptic inhibition or other mechanisms reducing photic input to the SCN.
The actions of THIP differed from the actions of muscimol on the circadian system when administered during the subjective day. THIP microinjected during the day did not have any phase altering effect. Muscimol induces large phase advances at this time (23, 46) , a finding that was replicated in the present study.
We cannot rule out the possibility that our concentration of THIP was too low to cause phase advances during the day. However, if higher concentrations of drug were needed to elicit phase alterations, one possible explanation would be that several populations of receptors are present and are activated at different agonist concentrations.
During the night, both THIP and muscimol prevented the ability of light to phase-shift behavioral activity and block light-induced Per1 and Per2 mRNA increases in the SCN. These findings suggest that a subpopulation of GABA A receptors selectively sensitive to THIP inhibited the ability of light to reset circadian timing, while a separate population of GABA A receptors is responsible for the ability of GABA to cause phase shifts. Agonists and positive allosteric modulators (PAM) of the GABA A receptor possess the well characterized ability to induce phase advances during the day and inhibit the effects of light during the night (17, 18, 20, 36, 37, 39, 46, 47, 52) . The present study demonstrates that THIP is unique among GABA A receptor agonists in its ability to inhibit the effects of light at night without direct phase altering effects during the subjective day.
These data support the hypothesis that there are two distinct subpopulations of GABA A receptors in the SCN, one selectively sensitive to THIP but both sensitive to muscimol, and that the THIP sensitive subpopulation is involved in the ability of GABA to block light-induced phase shifts.
Several labs have investigated the regional distribution of GABA A receptor subunits in the rodent brain. Of these, only one mouse study has looked for the δ subunit in the SCN. The δ subunit was found to be undetectable by western blot (41) . However, we have found no studies which looked for the δ subunit in the hamster SCN. A comparison of studies that have looked for the presence of other GABA receptor subunits in the SCN indicates a large degree of both species and technique differences (16, 25, 35, 41) . It will therefore be important to confirm the existence of the δ subunit protein in the SCN. Despite this, the current data provide evidence for the δ subunit's presence in the SCN. The potency of THIP is estimated to be 10 fold greater for the δ subunit (1, 5, 49) .
Thus, the ability of the SCN to respond to THIP provides strong evidence that the δ subunit is expressed in the SCN.
Our present understanding of the process by which the SCN integrates environmental stimuli is incomplete. These investigations suggest a novel mechanism by which the SCN may filter these entraining stimuli. GABA A receptor activation in the SCN is necessary and sufficient for entraining stimuli to reset circadian timing during the day (20, 46, 47) . The data in the current study, however, provides evidence supporting the hypothesis that not all GABA A 
Perspectives and Significance
Rhythmic sensitivity to light is a fundamental characteristic of the mammalian circadian system. These data provide evidence that GABA may drive THIP delivered to the SCN region just prior to a light pulse during the early subjective night (CT 13.5) also inhibited light-induced increases in Per2 mRNA.
The effect of light in saline treated animals for Per1 at both time points and Per2 in the early night was significantly greater than all other groups. There were no significant differences between any of the Per2 mRNA groups in the late night.
Bars represent mean ± SEM; *, p < 0.05. 
